When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRTX - Cortexyme picks lead 3CLpro inhibitor for the treatment of COVID-19
Cortexyme Inc.
Cortexyme (CRTX) announces the selection of a lead 3CLpro inhibitor COR803 for the treatment of COVID-19 infections.The company argued that COR803 has beneficial properties over other COVID-19 therapeutics and 3CLpro inhibitors in development.Shares down marginally premarket.